Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation

Long-term results of prospective randomized trials comparing triple immunosuppressive strategies combining tacrolimus (TAC) or cyclosporine A (CsA) with mycophenolate mofetil (MMF) and steroids after heart transplantation (HTX) are rarely published. Therefore, we collected long-term follow-up data o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2013-02, Vol.95 (4), p.629-634
Hauptverfasser:	Guethoff, Sonja, Meiser, Bruno M, Groetzner, Jan, Eifert, Sandra, Grinninger, Carola, Ueberfuhr, Peter, Reichart, Bruno, Hagl, Christian, Kaczmarek, Ingo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Chi-Square Distribution Classification Clinical trials Coronary Artery Disease - etiology Coronary Artery Disease - therapy Cyclosporine - adverse effects Cyclosporine - blood Cyclosporine - therapeutic use Cyclosporins Cytomegalovirus Data processing Diabetes mellitus Drug Monitoring Drug Therapy, Combination Female Germany Graft rejection Graft Rejection - immunology Graft Rejection - mortality Graft Rejection - prevention & control Graft Survival - drug effects Heart transplantation Heart Transplantation - adverse effects Heart Transplantation - immunology Heart Transplantation - mortality Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - blood Immunosuppressive Agents - therapeutic use Infection Kaplan-Meier Estimate Logistic Models Male Malignancy Middle Aged Mycophenolate mofetil Mycophenolic Acid - adverse effects Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - blood Mycophenolic Acid - therapeutic use Prospective Studies Renal function Risk Factors Steroid hormones Survival Tacrolimus Tacrolimus - adverse effects Tacrolimus - blood Tacrolimus - therapeutic use Time Factors Treatment Outcome Vascular diseases Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!